News
Market and company headlines
RPIDAll
Loading
13:00Oct 211 Story
16:00Oct 201 Story
04:00-09:00Oct 22 Stories
Friday's pre-market session: top gainers and losers
Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers NewGenIvf Group (NASDAQ:NIVF) stock moved upwards by 56.7% to $0.16 during Friday's pre-market session. Stablecoin Development (AMEX:SDEV) stock rose 30.86% to $4.79. The company's market cap stands at
02:00Sep 291 Story
15:00Sep 241 Story
17:00Aug 72 Stories
Rapid Micro Biosystems, Inc. Q2 2026 Earnings Call Summary
Moby summary of Rapid Micro Biosystems, Inc.'s Q2 2026 earnings call
Rapid Micro Biosystems Inc (RPID) (Q2 2026) Earnings Call Highlights: Record Revenue and ...
Company exceeds Q2 guidance with 11% revenue growth and record gross margin, while reaffirming full-year outlook and advancing key partnerships.
10:00Aug 72 Stories
Rapid Micro Biosystems, Inc. (RPID) Q2 2026 Earnings Call Transcript
Rapid Micro Biosystems, Inc. (RPID) Q2 2026 Earnings Call August 7, 2026 8:30 AM EDTCompany ParticipantsMichael Beaulieu - Vice President of Investor...
Rapid Micro Biosystems Q2 Earnings Call Highlights
Rapid Micro Biosystems (NASDAQ:RPID) reported second-quarter revenue of $8.1 million, up 11% from $7.3 million a year earlier and above the company’s prior guidance, as consumable sales, service activity and recurring revenue increased. The company placed four Growth Direct Systems during the quart
08:00Aug 72 Stories
Rapid Micro Biosystems (NASDAQ:RPID) Slips on Wider Q2 Loss as Revenue Matches Estimates
RPID Q2 revenue meets estimates at $8.05M, but adjusted EPS loss of -$0.27 misses; shares fall ~3.8% pre-market.
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Tops Revenue Estimates
Rapid Micro Biosystems (RPID) delivered earnings and revenue surprises of -3.85% and +3.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
03:00-08:00Aug 72 Stories
Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results
Reports second quarter 2026 total revenue of $8.1 million, representing 11% growth compared to the second quarter of 2025 Achieved a significant milestone with the 200th Growth Direct system placed globally; placed four Growth Direct systems and completed nine validations in the second quarter 2026Second quarter consumable revenue increased more than 20% year-over-yearSecond quarter recurring revenue increased 14% year-over-year; comprised 63% of total revenue Reports record second quarter total
Rapid Micro Biosystems Affirms FY2026 Sales Guidance of $37.000M-$41.000M vs $39.133M Est
Rapid Micro Biosystems (NASDAQ:RPID) affirms FY2026 sales outlook from $37.000 million-$41.000 million to $37.000 million-$41.000 million vs $39.133 million estimate.